Ali Mohamed
Senior Vice President, CMC Immatics
Senior operations and manufacturing development leader with an extensive background and experience managing successful cGMP operations, facilities, and supply chain materials management for the cell & gene therapy industry.
Plays an integral leadership role by fostering cross-functional collaboration, and building strong and diverse teams in dynamic environment. Over 15 years of experience managing the various facets of the cell & gene therapy industry with all the necessary regulatory compliance.
Seminars
Thursday 26th February 2026
Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe
1:30 pm
- Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
- Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards
Thursday 26th February 2026
Driving Efficiency & Unlocking Scalability for PRAME Cell Therapy Manufacturing
2:00 pm
- Anzu-cel is TCR T-cell therapy directed against PRAME, a target expressed in more than 50 cancers
- Scaling out efficiently: horizontal expansion to increase speed and throughput
- Preparing for commercial manufacturing through operational excellence
